Related Experiment Video
Updated: Mar 12, 2026

05:30
Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
Published on: August 8, 2025
676
Splenic Involvement in Hereditary Hemorrhagic Telangiectasia
Susumu Takamatsu1, Kota Sato1, Shunsuke Kato1
1Department of Surgery, Musashino Red Cross Hospital, 1-26-1 Kyonan-cho, Musashino-shi, Tokyo 180-8610, Japan.
Case Reports in Medicine
|November 4, 2016
Summary
Hereditary hemorrhagic telangiectasia (HHT) can cause rare symptomatic splenic lesions. Imaging revealed abnormal vessels in the spleen, which resolved after splenectomy, confirming HHT involvement.
Area of Science:
- Vascular Medicine
- Genetics
- Radiology
Background:
- Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant genetic disorder.
- Splenic involvement in HHT is uncommon, with few reported cases.
- Diagnosis of HHT relies on clinical criteria, such as the Curaçao criteria.
Purpose of the Study:
- To report a case of symptomatic splenic involvement in a patient with HHT.
- To highlight the utility of imaging modalities in diagnosing rare HHT manifestations.
- To emphasize the importance of considering HHT in patients with unexplained vascular abnormalities.
Main Methods:
- Case report of a 33-year-old male with epigastric pain, epistaxis, and family history of HHT.
- Diagnostic imaging included computed tomography (CT) and magnetic resonance imaging (MRI).
- Surgical intervention (splenectomy) and histopathological examination of the spleen.
Main Results:
- Imaging revealed splenomegaly, a hypervascular splenic mass, pulmonary arteriovenous malformation, and liver parenchymal changes suggestive of arteriosystemic shunts.
- The patient met the Curaçao criteria for HHT.
- Post-splenectomy, the patient's symptoms resolved; pathological examination confirmed abnormal splenic vessels, not a tumor.
Conclusions:
- Symptomatic splenic involvement is a rare but possible manifestation of HHT.
- Advanced imaging techniques are crucial for identifying and diagnosing such rare presentations.
- Splenectomy can be an effective treatment for symptomatic splenic lesions in HHT patients.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
709
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
709
Esophageal Varices-I: Introduction
1.9K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.9K
Disorders of Hemostasis
2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K

